Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annie Im

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Haematologica|May 25, 2023
Patient-reported treatment response in chronic graft-<i>versus</i>-host diseaseAnnie Im, Iskra Pusic, Lynn Onstad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2023
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complicationsStefanie J Hannan, Carlo J Iasella, Rachel M Sutton, et al.
Cytotherapy|September 3, 2017
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemiaMichael Boyiadzis, Mounzer Agha, Robert L Redner, et al.
Hemasphere|June 24, 2022
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host DiseaseAna Zelic Kerep, Filip Pirsl, Seth Steinberg, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Transplantation and Cellular Therapy|May 9, 2021
Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working CommitteeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|January 30, 2021
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
American Journal of Hematology|March 12, 2025
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell TransplantationRohtesh S Mehta, Hannah Choe, Jennifer Saultz, et al.
Haematologica|June 16, 2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trialHelene M Schoemans, Kathy Goris, Raf Van Durm, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Haematologica|May 25, 2023
Patient-reported treatment response in chronic graft-<i>versus</i>-host diseaseAnnie Im, Iskra Pusic, Lynn Onstad, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 12, 2017
Predictors for Permanent Discontinuation of Systemic Immunosuppression in Severely Affected Chronic Graft-Versus-Host Disease PatientsLauren M Curtis, Filip Pirsl, Seth M Steinberg, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 1, 2023
Lung transplant recipients with telomere-mediated pulmonary fibrosis have increased risk for hematologic complicationsStefanie J Hannan, Carlo J Iasella, Rachel M Sutton, et al.
Cytotherapy|September 3, 2017
Phase 1 clinical trial of adoptive immunotherapy using "off-the-shelf" activated natural killer cells in patients with refractory and relapsed acute myeloid leukemiaMichael Boyiadzis, Mounzer Agha, Robert L Redner, et al.
Hemasphere|June 24, 2022
Determinants and Clinical Significance of Musculoskeletal Symptoms in Patients With Chronic Graft-Versus-Host DiseaseAna Zelic Kerep, Filip Pirsl, Seth Steinberg, et al.
Haematologica|July 24, 2025
Longer time from diagnosis to initiation of hypomethylating agents plus venetoclax for acute myeloid leukemia does not worsen survival: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)Samuel J Yates, Julian J Weiss, Abigail Sneider, et al.
Transplantation and Cellular Therapy|May 9, 2021
Systematic Reviews in Hematopoietic Cell Transplantation and Cellular Therapy: Considerations and Guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and Center for International Blood and Marrow Transplant Research Late Effects and Quality of Life Working CommitteeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
Bone Marrow Transplantation|January 30, 2021
Systematic reviews in hematopoietic cell transplantation and cellular therapy: considerations and guidance from the American Society for Transplantation and Cellular Therapy, European Society for Blood and Marrow Transplantation, and the Center for International Blood and Marrow Transplant Research late effects and quality of life working committeeAkshay Sharma, Sherif M Badawy, Elizabeth M Suelzer, et al.
American Journal of Hematology|March 12, 2025
Impact of Donor Age and Donor Cytomegalovirus Serostatus on Outcomes After Related Donor Allogeneic Hematopoietic Stem Cell TransplantationRohtesh S Mehta, Hannah Choe, Jennifer Saultz, et al.
Haematologica|June 16, 2018
The eGVHD App has the potential to improve the accuracy of graft-versus-host disease assessment: a multicenter randomized controlled trialHelene M Schoemans, Kathy Goris, Raf Van Durm, et al.
Pageof 5